CureVac Company
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Investors
.jpeg)
Technology:
RNA
Industry:
RNA
Headquarters:
Tübingen, Baden-Wurttemberg, Germany
Founded Date:
2000-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
17
Total Funding:
73319243
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-02-02
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership